Any feedback?
Literature summary extracted from
- Effect of fucoidan on the biotinidase kinetics in human hepatocellular carcinoma (2009), Anticancer Res., 29, 1211-1217.
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.5.1.12 | biotin | product inhibition, decreased by fucoidan in hepatocellular carcinoma, but increased in liver cirrhosis | Homo sapiens |  |
KM Value [mM]
| EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 3.5.1.12 | additional information | - |
additional information | enzyme kinetics in liver from hepatoma patients with additional hepatitis B or hepatitis C infection, or from patients with chronic active hepatitis or cirrhosis | Homo sapiens |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.5.1.12 | Homo sapiens | - |
- |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 3.5.1.12 | hepatocellular carcinoma cell | - |
Homo sapiens | - |
| 3.5.1.12 | HuH-6 cell | - |
Homo sapiens | - |
| 3.5.1.12 | liver | from hepatoma patients with additional hepatitis B or hepatitis C infection, or from patients with chronic active hepatitis or cirrhosis | Homo sapiens | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
